APPLICATIONS PUBLISHED 24 NOVEMBER 2004
Published: 2-Aug-2005
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Purification of red blood cells by separation and diafiltration
Biopure 1478388*
Treatment for diseases of the eye, inner ear and central nervous system
CEVEC Pharmaceuticals 1478389*
Novel complexes for inducing an immune response
ISIS Innovation 1478390*
Method for providing prophylaxis for tuberculosis in HIV positive individuals
Khamar, Bakulesh; Modi, Rajiv 1478391*
An obligate domain-swapped dimer of cyanovirin with enhanced anti-viral activity
The Government of the United States of America, as represented by the Secretary, Department of Health & Human Services 1478392*
Anti-pathogen treatments
Massachusetts Institute of Technology 1478393*
Polypeptide formulation
Immunex Corp 1478394*
Rapid lateral flow assay for determining exposure to mycobacterium, tuberculosis and other mycobacteria
The Government of the United States of America as represented by the Navy Medical Research Center Office of Counsel 1478395*
Process for the preparation of a nutrient formulation
Chemstop 1478396*
Pharmaceutical combination of angiotensin II antagonists and angiotensin I converting enzyme inhibitors
Boehringer Ingelheim 1478397*
New medicinal compsns on the basis of anticholinergic agents and EGFR kinase inhibitors
Boehringer Ingelheim Pharma 1478398*
Oral dosage form containing a PDE-4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient
Altana Pharma 1478399*
Therapy for the treatment of migraine comprising anticonvulsant derivatives and antimigraine agents
Ortho-McNeil Pharmaceutical 1478400*
Compsns comprising dietary fat complexer and methods for their use
Art Jen Complexus 1478401*
Preparation for oxidation-sensitive compounds and method for making same
Vachy, Robert 1478402*
Responsive microgel, and methods related thereto
Supratek Pharma 1478403*
Ophthalmic antibiotic drug formulations containing a cyclodextrin compound and cetyl pyridinium chloride
Pharmacia Corp 1478404*
Beta-homolysine conjugates and their use as transport enhancer
Novartis 1478405*
Compsns for delivery of therapeutics and other materials, and methods of making and using the same
Pharmain 1478406*
Use of 13C labelled substance for measuring lung function
Cambridge Isotope Laboratories 1478407*
ACC inhibitors
Pfizer 1478437*
Methods and compsns for the treatment of asthma and related disorders
Atopic 1478438*
Polyamine compounds and compsns for use in conjunction with cancer therapy
Wisconsin Alumni Research Foundation 1478618*
A process for preparing a phenylalanine derivative and intermediates thereof
Tanabe Seiyaku 1478619*
Phenethanolamine derivatives for treatment of respiratory diseases
Glaxo Group 1478620*
Crystalline anhydrous and monohydrate benzoate salts of (2'S,3S)-3-hydroxy-N-2N-methyl-N-4-(N-propylamino-carbonyl)phenyl)amino-2-phenyl-ethylpyrrolidine
Pfizer 1478622*
Novel coupling agents, the active intermediates and the conjugates thereof, and the use of said conjugates in diagnostic methods
Biomerieux 1478623*
Chemical compounds
AstraZeneca 1478624*
Processes and intermediates useful in preparing beta-3-adrenergic receptor agonists
Pfizer 1478625*
Guanidino compounds
Chiron 1478626*
Method
AstraZeneca 1478627*
N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials
Pharmacia & Upjohn 1478629*
Process and intermediates for preparing phenylthiomethyl-thiazoles or -oxazoles
SmithKline Beecham 1478630*
Therapeutic compounds
AstraZeneca 1478631*
Substituted aryl alkenoic acid heterocyclic amides possessing pungent taste
Council of Scientific and Industrial Research; An Indian Registered Body under the Registration of Societies Act 1478632*
Furanone derivatives
Galileo Pharmaceuticals 1478634*
Process for the preparation of citalopram
Matrix Laboratories 1478635*
Amorphous citalopram
Cipla 1478636*
Amorphous citalopram salts
Cipla 1478637*
Purification of citalopram
Cipla 1478638*
Fused tricyclic heterocycles useful for treating hyperproliferative disorders
Bayer Pharmaceuticals 1478639*
Process for the manufacture of HMG-CoA reductase inhibitory mevalonic acid derivatives
Novartis 1478640*
Process for preparing an intermediate useful for the asymmetric synthesis of duloxetine
Eli Lilly 1478641*
Synthesis of gatifoxacin
Teva Pharmaceuticals 1478642*
5-heteroaryl substituted indoles
H Lundbeck 1478643*
Quinolinone derivatives for treating cell proliferation related disorders
Amgen 1478645*
Azabicyclic compounds with Alfa7 nicotinic acetylcholine receptor activity
Pharmacia & Upjohn 1478646*
(6S)-5,6,7,8-tetrahydrofolic acid production process
GMT Fine Chemicals 1478647*
Phosphorus-containing compounds uses thereof
Ariad Gene Therapeutics 1478648*
Novel cephalosporin compounds and process for preparing the same
LG Life Sciences 1478649*
Novel boronate esters
Biocon 1478650*
